Levetiracetam
Who holds supplier records for Levetiracetam? 36 organisations hold a current record for Levetiracetam: an active US FDA Type II Drug Master File or a CEP. A further 11 organisations have only historical (inactive) DMF filings. 32 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (25) and China (9); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Levetiracetam: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/levetiracetam
Reading the evidence
- 36 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
25 of the 34 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 20 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Levetiracetam expires 14 Mar 2034. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (36)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Levetiracetam. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Divis LaboratoriesIndiaCEP Company GMP cert on recordActive DMF 30185, 16894 · latest filing Jan 2016
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 30626, 17738 · latest filing Jun 2016
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 30119, 22235, 37852 +1 · latest filing Dec 2022
- AMOLI ORGANICS PRIVATE LTDIndiaCEPActive DMF 23585, 25762 · latest filing Feb 2012
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 19387 · latest filing Apr 2006
- Aurore Life SciencesIndiaCEP Company GMP cert on recordActive DMF 34097 · latest filing Aug 2019
- CHIERON ACTIVE INGREDIENTS PRIVATE LTDIndiaCEPActive DMF 35316 · latest filing Oct 2020
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 16966 · latest filing Nov 2003
- EMNAR PHARMA PRIVATE LTDIndiaCEPActive DMF 35441 · latest filing Dec 2020
- Granules India LimitedIndiaCEP Company GMP cert on recordActive DMF 37775 · latest filing Dec 2022
- INNOVARE LABS PRIVATE LTDIndiaCEPActive DMF 34593 · latest filing Feb 2020
- Iol Chemicals And Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 36374 · latest filing Nov 2021
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 24200 · latest filing Oct 2010
- Lupin LimitedIndiaCEP Company GMP cert on recordActive DMF 19080 · latest filing Dec 2005
- MSN LIFE SCIENCES PRIVATE LIMITEDIndiaCEP Company GMP cert on recordActive DMF 33608 · latest filing Feb 2019
- Neuland Laboratories LimitedIndiaCEPActive DMF 17799 · latest filing Nov 2004
- RUI Laboratories Private LimitedIndiaCEPActive DMF 41245 · latest filing Mar 2025
- SMS Pharmaceuticals limitedIndiaCEP Company GMP cert on recordActive DMF 28431 · latest filing Jun 2014
- SOLARA ACTIVE PHARMA SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 26500 · latest filing Sept 2012
- SRINI PHARMACEUTICALS PRIVATE LIMITEDIndiaCEP Company GMP cert on recordActive DMF 24757 · latest filing Mar 2011
- Sun Pharmaceutical Industries LimitedIndiaCEP Company GMP cert on recordActive DMF 21414 · latest filing Mar 2008
- Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.ChinaCEPActive DMF 25005 · latest filing May 2011
- Hubei Shinewell Pharmaceutical Co., Ltd.ChinaActive DMF 44329 · latest filing Jun 2026
- ORBION PHARMACEUTICALS PRIVATE LTDIndia Company GMP cert on recordActive DMF 19747 · latest filing Sept 2006
- SHAOXING JINGXIN PHARMACEUTICALS CO LTDChinaActive DMF 35629 · latest filing Apr 2021
- VASUDHA PHARMA CHEM LTDIndiaActive DMF 38130 · latest filing Mar 2023
- ESTEVE QUIMICA SACEP Company GMP cert on recordInactive DMF 17327 · latest filing Apr 2004
- IndiaCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
- SECOND PHARMA CO LTDChinaCEPInactive DMF 25120 · latest filing Jun 2011
- Shaoxing Jingxin Pharmaceutical Co., Ltd.ChinaCEP
- ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO LTDCEP Company GMP cert on record
- Zhejiang Jiangbei Pharmaceutical Co., Ltd.ChinaCEPInactive DMF 34222 · latest filing Dec 2019
- WEIFANG HISHINE PHARMACEUTICAL CO., LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- ABA CHEMICALS (SHANGHAI) LIMITEDChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (32)
Certificates of Suitability on the EDQM register for Levetiracetam, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 47 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| WEIFANG HISHINE PHARMACEUTICAL CO., LTD. Weifang | CN | CEP 2011-035 - Rev 06 Levetiracetam | Sept 2026 | — |
| INNOVARE LABS PRIVATE LIMITED Visakhapatnam | IN | CEP 2019-269 - Rev 01 Levetiracetam | Sept 2026 | — |
| SHAOXING JINGXIN PHARMACEUTICAL CO., LTD. Shangyu | CN | CEP 2021-267 - Rev 02 Levetiracetam, Process II | Jul 2026 | — |
| NEULAND LABORATORIES LIMITED Hyderabad | IN | CEP 2011-380 - Rev 09 Levetiracetam | Jul 2026 | — |
| IOL CHEMICALS AND PHARMACEUTICALS LIMITED Ludhiana | IN | CEP 2021-343 - Rev 01 Levetiracetam | Jun 2026 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2010-245 - Rev 05 Levetiracetam | Mar 2026 | — |
| ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO., LTD Linhai City | CN | CEP 2023-031 - Rev 01 Levetiracetam, Site 2 | Mar 2026 | Inspected Oct 2025 France |
| JUBILANT BIOSYS LIMITED Mysuru | IN | CEP 2011-159 - Rev 02 Levetiracetam | Jan 2026 | — |
| CHIERON ACTIVE INGREDIENTS PRIVATE LIMITED Hyderabad | IN | CEP 2023-046 - Rev 02 Levetiracetam | Dec 2025 | — |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | CEP 2021-034 - Rev 01 Levetiracetam | Oct 2025 | — |
| AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad | IN | CEP 2021-196 - Rev 01 Levetiracetam, Form I | Sept 2025 | — |
| GRANULES INDIA LIMITED Hyderabad | IN | CEP 2023-138 - Rev 01 Levetiracetam | Aug 2025 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | CEP 2011-084 - Rev 02 Levetiracetam | May 2025 | — |
| SRINI PHARMACEUTICALS PRIVATE LIMITED Choutuppal | IN | CEP 2018-176 - Rev 01 Levetiracetam | Feb 2025 | Inspected Sept 2025 Sweden |
| HETERO LABS LIMITED Hyderabad | IN | CEP 2014-113 - Rev 02 Levetiracetam, Form-I Process-II | Nov 2024 | — |
| SOLARA ACTIVE PHARMA SCIENCES LIMITED Chennai | IN | CEP 2012-324 - Rev 02 Levetiracetam | Oct 2024 | — |
| LAURUS LABS LIMITED Hyderabad | IN | CEP 2023-133 - Rev 00 Levetiracetam | Sept 2024 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | CEP 2022-399 - Rev 01 Levetiracetam, Process VII, micronised and non-micronised | Aug 2024 | Inspected May 2026 Italy |
| IPCA LABORATORIES LIMITED Mumbai | IN | CEP 2024-009 - Rev 00 Levetiracetam | Aug 2024 | — |
| LUPIN LIMITED Mumbai | IN | CEP 2013-242 - Rev 03 Levetiracetam | Mar 2024 | — |
| MSN LIFE SCIENCES PRIVATE LIMITED Bhiknoor Village | IN | CEP 2019-300 - Rev 03 Levetiracetam | Mar 2024 | — |
| EMNAR PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2021-500 - Rev 01 Levetiracetam | Oct 2023 | — |
| Rui Laboratories Private Limited Visakhapatnam | IN | R0-CEP 2021-444 - Rev 00 Levetiracetam | Jun 2023 | — |
| EXEMED PHARMACEUTICALS Vadodara | IN | R0-CEP 2020-199 - Rev 00 Levetiracetam | Jun 2022 | — |
| AMOLI ORGANICS PRIVATE LIMITED Mumbai | IN | R1-CEP 2014-270 - Rev 00 Levetiracetam | Sept 2021 | — |
| ABA CHEMICALS (SHANGHAI) LIMITED Shanghai | CN | R1-CEP 2015-035 - Rev 00 Levetiracetam | Aug 2021 | — |
| ESTEVE QUIMICA S.A. Barcelona | ES | R1-CEP 2011-042 - Rev 05 Levetiracetam, Code product 2577 | Jun 2021 | — |
| SECOND PHARMA CO., LTD. Shangyu City | CN | R1-CEP 2014-219 - Rev 00 Levetiracetam | Dec 2020 | — |
| SMS PHARMACEUTICALS LIMITED Hyderabad | IN | R1-CEP 2014-275 - Rev 00 Levetiracetam | Dec 2020 | — |
| DIVI'S LABORATORIES LIMITED Hyderabad | IN | R1-CEP 2014-079 - Rev 01 Levetiracetam, Process B | Dec 2020 | — |
| ZHEJIANG JIANGBEI PHARMACEUTICAL CO., LTD. Taizhou City | CN | R1-CEP 2012-084 - Rev 03 Levetiracetam | Sept 2020 | — |
| ZHEJIANG APELOA JIAYUAN PHARMACEUTICAL CO., LTD. Hengdian | CN | R1-CEP 2013-246 - Rev 00 Levetiracetam | Mar 2020 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (11)
Organisations whose Type II DMFs for Levetiracetam are no longer active. These show a past filing, not current supply.
Show all 11 historical records
- India · Inactive DMF 21743, 31149 · filed Nov 2016
- India · Inactive DMF 27458 · filed Sept 2013
- China · Inactive DMF 26194 · filed Jun 2012
- Inactive DMF 21747 · filed Jun 2008
- MYLAN LABORATORIES LTDInactive DMF 21201 · filed Dec 2007
- India · Inactive DMF 21122 · filed Nov 2007
- SIGNA SA DE CVInactive DMF 20412 · filed Apr 2007
- United States · Inactive DMF 19738 · filed Aug 2006
- India · Inactive DMF 19104 · filed Jan 2006
- RANBAXY LABORATORIES LTDInactive DMF 19051 · filed Dec 2005
- Teva Pharmaceutical Industries Ltd.Israel · Inactive DMF 19033 · filed Dec 2005
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (153 listed products contain Levetiracetam). The latest listed patent expires 14 Mar 2034. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Levetiracetam is an anticonvulsant medication used to treat epilepsy. It is known to inhibit burst firing without affecting normal neuronal excitability, thereby preventing the propagation of seizure activity.
Chemical identity
- IUPAC name
- 2-(2-oxopyrrolidin-1-yl)butanamide
- Canonical SMILES
- CCC(C(=O)N)N1CCCC1=O
- InChIKey
- HPHUVLMMVZITSG-UHFFFAOYSA-N
- Synonyms
- Keppra API, Etiracetam, 2-(2-oxopyrrolidin-1-yl)butanamide, alpha-Ethyl-2-oxo-1-pyrrolidineacetamide, Etiracetamum, UCB-6474, RefChem:139255, UCB 6474, Etiracetam [INN], Levetiracetam-d3, (R)-Levetiracetam, Etiracetamum [INN-Latin]
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Physiologic effect
- Decreased Central Nervous System Disorganized Electrical Activity
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Levetiracetam?
36 organisations hold an active US FDA Type II Drug Master File or a CEP for Levetiracetam: Divis Laboratories (India), Hetero Labs Limited (India), Zhejiang Huahai Pharmaceutical Co., Ltd. (China), AMOLI ORGANICS PRIVATE LTD (India), APITORIA PHARMA PRIVATE LTD (India), Aurore Life Sciences (India), CHIERON ACTIVE INGREDIENTS PRIVATE LTD (India) and Dr. Reddy's Laboratories Ltd. (India), and 28 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Levetiracetam Drug Master Files are active?
Divis Laboratories (DMF 30185, 16894), Hetero Labs Limited (DMF 30626, 17738), Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 30119, 22235), AMOLI ORGANICS PRIVATE LTD (DMF 23585, 25762), APITORIA PHARMA PRIVATE LTD (DMF 19387), Aurore Life Sciences (DMF 34097), CHIERON ACTIVE INGREDIENTS PRIVATE LTD (DMF 35316) and Dr. Reddy's Laboratories Ltd. (DMF 16966) and 18 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Levetiracetam records mean?
11 organisations have only inactive Type II DMFs for Levetiracetam. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Levetiracetam have a European Certificate of Suitability?
Yes. 32 organisations hold a valid CEP for Levetiracetam on the EDQM register, including WEIFANG HISHINE PHARMACEUTICAL CO., LTD. Weifang (CN), INNOVARE LABS PRIVATE LIMITED Visakhapatnam (IN), SHAOXING JINGXIN PHARMACEUTICAL CO., LTD. Shangyu (CN), NEULAND LABORATORIES LIMITED Hyderabad (IN), IOL CHEMICALS AND PHARMACEUTICALS LIMITED Ludhiana (IN) and APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and 26 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Levetiracetam?
Yes. The latest patent listed for an approved US product containing Levetiracetam expires 14 Mar 2034, across 153 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Levetiracetam supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Levetiracetam?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.